NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancer

dc.contributor.author	Mehraj, Umar
dc.contributor.author	Maimekov, Uran
dc.contributor.author	Manzoor, Shaista
dc.contributor.author	Cordova, Emily
dc.contributor.author	Patel, Manasiben
dc.contributor.author	Mancera-Ortiz, Ikeer Y
dc.contributor.author	Howell, Stefanie
dc.contributor.author	Davis-Gilbert, Zachary W
dc.contributor.author	Wang, Mu-En
dc.contributor.author	Chen, Ming
dc.contributor.author	Park, Jung Wook
dc.contributor.author	Wang, Yuzhuo
dc.contributor.author	Armstrong, Andrew J
dc.contributor.author	Huang, Jiaoti
dc.contributor.author	Drewry, David H
dc.contributor.author	Mitrofanova, Antonina
dc.contributor.author	Macias, Everardo
dc.date.accessioned	2025-12-19T20:36:58Z
dc.date.available	2025-12-19T20:36:58Z
dc.date.issued	2025-11-13
dc.identifier.uri	https://hdl.handle.net/10161/33797
dc.rights.uri	https://creativecommons.org/licenses/by-nc/4.0
dc.title	NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancer
dc.type	Preprint
duke.contributor.orcid	Chen, Ming\|0000-0002-3470-1062
duke.preprint.url	10.1101/2025.11.12.687734
pubs.organisational-group	Duke
pubs.organisational-group	School of Medicine
pubs.organisational-group	Basic Science Departments
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Institutes and Centers
pubs.organisational-group	Cell Biology
pubs.organisational-group	Pathology
pubs.organisational-group	Duke Cancer Institute

Files

Now showing 1 - 1 of 1